About-cancer / lapaʻau / lāʻau / ʻōpū
Ua ʻae ʻia nā lāʻau no ka ʻōpū (Gastric) maʻi ʻaʻai
Ua helu ʻia kēia ʻaoʻao i nā lāʻau lapaʻau maʻi ʻaʻai i ʻae ʻia e ka Food and Drug Administration (FDA) no ka maʻi ʻōpū o ka ʻōpū (gastric) Loaʻa i ka papa inoa nā inoa generic a me nā inoa. Hoʻokomo pū ʻia kēia ʻaoʻao i nā hui lāʻau lapaʻau maʻamau i hoʻohana ʻia i ka maʻi ʻaʻai ʻōpū (gastric). Ua ʻae ʻia nā lāʻau āpau e kēlā me kēia hui. Eia nō naʻe, ʻaʻole ʻae ʻia nā hui pū lāʻau ponoʻī iā lākou, ʻoiai lākou e hoʻohana ākea.
Loulou nā inoa lāʻau i nā hōʻuluʻulu manaʻo ʻike maʻi maʻi ʻo NCI. Hiki paha i nā lāʻau i hoʻohana ʻia i ka ʻōpū ʻōpū (gastric) ʻaʻole i helu ʻia ma aneʻi.
MA K PIA ʻaoʻao
- Ua ʻae ʻia nā lāʻau no ka ʻōpū (Gastric) maʻi ʻaʻai
- Hoʻohui ʻia nā hui lāʻau i hoʻohana ʻia i ka ʻōpū (Gastric) maʻi ʻaʻai
- Ua ʻae ʻia nā lāʻau no Gastroenteropancreatic Neuroendocrine Tumors
Ua ʻae ʻia nā lāʻau no ka ʻōpū (Gastric) maʻi ʻaʻai
Cyramza (Ramucirumab)
ʻO Docetaxel
Doxorubicin Hydrochloride
5-FU (Fluorouracil injection)
Pākuʻi Fluorouracil
Herceptin (Trastuzumab)
Keytruda (Pembrolizumab)
Lonsurf (Trifluridine a me Tipiracil Hydrochloride)
ʻO Mitomycin C
Pembrolizumab
ʻO Ramucirumab
ʻO Taxotere (Docetaxel)
ʻO Trastuzumab
ʻO Trifluridine lāua ʻo Tipiracil Hydrochloride
Hoʻohui ʻia nā hui lāʻau i hoʻohana ʻia i ka ʻōpū (Gastric) maʻi ʻaʻai
FU-LV
TPF
XELIRI
Ua ʻae ʻia nā lāʻau no Gastroenteropancreatic Neuroendocrine Tumors
ʻO Afinitor (Everolimus)
ʻO Afinitor Disperz (Everolimus)
Everolimus
ʻO Lanreotide Acetate
ʻO Somatuline Depot (Lanreotide Acetate)
